These defects—including shrinkage, loosening, and migration—caused pain, bone loss, and the need for costly revision surgeries.
Patients claim that Cartiva’s negligence led to significant harm. The implant was originally marketed as a minimally invasive alternative to toe fusion for arthritis patients but was later recalled in October 2024.
Lawsuits claim that Cartiva knowingly sold defective big toe implants without warning patients. The implant was recalled in October 2024. You may be eligible for compensation.
Our team will call you as soon as possible, usually within 15 minutes, to discuss your options and collect information needed to get the settlement you deserve. This is completely free with no obligations.
Your attorney will fight for you to receive the best possible compensation. There are no up-front costs to you. Your attorney will only get paid when a settlement is won for your case.